• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风湿性疾病患者血浆和滑液中SC5b-9补体复合物的水平。

Levels of SC5b--9 complement complex in plasma and synovial fluid of patients with rheumatic disease.

作者信息

Rus V, Malide D, Boloşiu H D, Parasca I, Duţu A L

机构信息

Department of Rheumatology, Medical Clinic No. 2, Cluj-Napoca, Romania.

出版信息

Med Interne. 1990 Oct-Dec;28(4):305-10.

PMID:2100875
Abstract

Activation of the terminal complement pathway leads to formation of the C5b--9 complex. The main effects of C5b--9 generation are tissue injury by cell lysis or by stimulation of proinflammatory mediators. In a study carried out in 42 patients, using polyclonal antibodies against C5b--9 neoantigens and C9 in an ELISA assay, we found significantly higher levels of SC5b--9 complex in plasma from the 18 patients with active systemic lupus erythematosus than those found in 10 healthy controls (p less than 0.005). In the 18 patients presenting rheumatoid arthritis and the 6 with progressive systemic sclerosis the plasma levels of SC5b--9 complex did not differ significantly from those in controls. The SC5b--9 levels found in the synovial fluid samples from the 16 rheumatoid arthritis patients were higher than the corresponding plasma ones. The ratio between synovial fluid and plasma levels was 1.2. Immunoperoxidase staining for C5b--9 was intense in three rheumatoid synovial membranes and absent in two normal synovial membranes obtained during meniscectomy. Increased levels of plasma and synovial fluid SC5b--9 reflect pathologic systemic or local activation of the complement carcase in systemic lupus erythematosus and respectively rheumatoid arthritis. Synovial membrane deposits of C5b--9 are indicative for the lytic and proinflammatory effects of complement activation.

摘要

终末补体途径的激活导致C5b-9复合物的形成。C5b-9生成的主要作用是通过细胞溶解或刺激促炎介质引起组织损伤。在一项对42例患者进行的研究中,使用酶联免疫吸附测定法(ELISA)检测针对C5b-9新抗原和C9的多克隆抗体,我们发现18例活动性系统性红斑狼疮患者血浆中的SC5b-9复合物水平显著高于10例健康对照者(p<0.005)。18例类风湿关节炎患者和6例进行性系统性硬化症患者血浆中SC5b-9复合物水平与对照者无显著差异。16例类风湿关节炎患者滑膜液样本中的SC5b-9水平高于相应的血浆水平。滑膜液与血浆水平之比为1.2。在3例类风湿滑膜组织中,C5b-9的免疫过氧化物酶染色呈强阳性,而在半月板切除术时获取的2例正常滑膜组织中未检测到。血浆和滑膜液中SC5b-9水平升高分别反映了系统性红斑狼疮和类风湿关节炎中补体系统的病理性全身或局部激活。滑膜组织中C5b-9的沉积表明补体激活具有溶解和促炎作用。

相似文献

1
Levels of SC5b--9 complement complex in plasma and synovial fluid of patients with rheumatic disease.风湿性疾病患者血浆和滑液中SC5b-9补体复合物的水平。
Med Interne. 1990 Oct-Dec;28(4):305-10.
2
[ELISA for detection of SC5b-9 levels in plasma and its clinical significance in SLE disease].[酶联免疫吸附测定法检测血浆中SC5b-9水平及其在系统性红斑狼疮疾病中的临床意义]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1993 Aug;15(4):302-5.
3
[Terminal complement complex (TTC) levels in plasma and urine from glomerular diseases: enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody against neoantigens of TCC].肾小球疾病患者血浆和尿液中终末补体复合物(TTC)水平:使用抗TCC新抗原单克隆抗体的酶联免疫吸附测定(ELISA)
Hokkaido Igaku Zasshi. 1990 Jan;65(1):74-85.
4
Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies.使用新抗原特异性单克隆抗体对类风湿性关节炎和骨关节炎患者关节组织中的补体激活进行免疫组织化学测定。
J Clin Lab Immunol. 1992;37(4):147-62.
5
Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries.采用酶联免疫吸附测定法(ELISA)对人动脉粥样硬化动脉中的终末C5b-9补体复合物进行定量评估。
Clin Exp Immunol. 1987 Aug;69(2):477-83.
6
Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.系统性红斑狼疮及其他肾小球疾病患者血浆中的终末补体复合物。
Clin Exp Immunol. 1987 Nov;70(2):417-24.
7
Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor.胰岛素依赖型(I型)糖尿病患者血浆中终末液相补体复合物SC5b-9的检测。与尿白蛋白排泄增加及血浆血管性血友病因子的关系。
Clin Exp Immunol. 1991 Apr;84(1):53-8.
8
Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus.系统性红斑狼疮患者血清中补体攻膜复合物的放射免疫测定
N Engl J Med. 1985 Jun 20;312(25):1594-9. doi: 10.1056/NEJM198506203122502.
9
[Complement activity in the serum and synovial fluid of various rheumatoid diseases].[各种类风湿疾病患者血清及滑液中的补体活性]
Verh Dtsch Ges Rheumatol. 1972;2:Suppl 2:106-10.
10
Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus.检测原发性干燥综合征或系统性红斑狼疮累及中枢神经系统患者脑脊液中活化的终末补体(C5b-9)。
J Immunol. 1987 Apr 1;138(7):2095-9.

引用本文的文献

1
Soluble Membrane Attack Complex: Biochemistry and Immunobiology.可溶性膜攻击复合物:生物化学与免疫生物学。
Front Immunol. 2020 Nov 10;11:585108. doi: 10.3389/fimmu.2020.585108. eCollection 2020.
2
Biological characterization of compounds from Rhinella schneideri poison that act on the complement system.从 Rhinella schneideri 毒液中筛选作用于补体系统的化合物的生物学特性研究。
J Venom Anim Toxins Incl Trop Dis. 2015 Aug 13;21:25. doi: 10.1186/s40409-015-0024-9. eCollection 2015.
3
Modulation of leukocyte recruitment and IL-8 expression by the membrane attack complex of complement (C5b-9) in a rabbit model of antigen-induced arthritis.
在抗原诱导性关节炎兔模型中补体膜攻击复合物(C5b-9)对白细胞募集和IL-8表达的调节作用
Inflammation. 2002 Dec;26(6):311-9. doi: 10.1023/a:1021420903355.